SCHEMBL24323528

SCHEMBL24323528

COCC(CCC(=O)OCc1ccccc1)NC=O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ EPHX1 P07099 1/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ HPGD P15428 1/20 0.43
▸ TSHR P16473 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.40
▸ TACR1 P25103 1/20 0.39
▸ ABCB1 P08183 1/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CTSB P07858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24298896 0.87 ALDH1A1 (0.45) ALDH1A1MAPK1L3MBTL1EPHX1MEN1
SCHEMBL26047547 0.82 ALDH1A1 (0.49) ALDH1A1MAPK1L3MBTL1MEN1KMT2A
SCHEMBL24235586 0.82 MEN1 (0.53) ALDH1A1MAPK1L3MBTL1MEN1KMT2A
SCHEMBL27847367 0.81 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1EPHX1MEN1
SCHEMBL28222599 0.79 ALDH1A1 (0.48) ALDH1A1MAPK1L3MBTL1MEN1KMT2A
SCHEMBL13996825 0.79 ALDH1A1 (0.48) ALDH1A1MAPK1L3MBTL1MEN1KMT2A
SCHEMBL27312654 0.79 FOLH1 (0.49) ALDH1A1MAPK1L3MBTL1MEN1KMT2A
SCHEMBL24591318 0.76 ALDH1A1 (0.46) ALDH1A1MAPK1L3MBTL1MEN1KMT2A
SCHEMBL14614908 0.75 ALDH1A1 (0.59) ALDH1A1MAPK1L3MBTL1MEN1KMT2A
SCHEMBL16333125 0.74 CTRB1 (0.54) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076620-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback